Ameriprise’s Genesco GCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.61M Buy
+55,446
New +$1.59M ﹤0.01% 3059
2025
Q3
Sell
-80,253
Closed -$1.58M 4108
2025
Q2
$1.58M Sell
80,253
-7,617
-9% -$159K ﹤0.01% 3075
2025
Q1
$1.87M Buy
87,870
+22,245
+34% +$774K ﹤0.01% 2939
2024
Q4
$2.81M Buy
65,625
+16,161
+33% +$531K ﹤0.01% 2732
2024
Q3
$1.34M Sell
49,464
-27,600
-36% -$767K ﹤0.01% 3095
2024
Q2
$1.99M Buy
77,064
+8,509
+12% +$223K ﹤0.01% 2866
2024
Q1
$1.93M Sell
68,555
-5
-0% -$144 ﹤0.01% 2889
2023
Q4
$2.41M Buy
68,560
+8,738
+15% +$269K ﹤0.01% 2780
2023
Q3
$1.84M Buy
59,822
+16,317
+38% +$463K ﹤0.01% 2853
2023
Q2
$1.09M Sell
43,505
-262,690
-86% -$7.61M ﹤0.01% 3133
2023
Q1
$11.3M Buy
306,195
+6,303
+2% +$276K ﹤0.01% 1676
2022
Q4
$13.8M Sell
299,892
-22,895
-7% -$1.04M ﹤0.01% 1472
2022
Q3
$12.7M Sell
322,787
-94,473
-23% -$5.05M ﹤0.01% 1482
2022
Q2
$20.8M Sell
417,260
-32,694
-7% -$1.96M 0.01% 1181
2022
Q1
$28.6M Buy
449,954
+20,389
+5% +$1.33M 0.01% 1096
2021
Q4
$27.6M Buy
429,565
+119,938
+39% +$7.61M 0.01% 1176
2021
Q3
$17.9M Sell
309,627
-119,686
-28% -$7.12M 0.01% 1348
2021
Q2
$27.3M Sell
429,313
-136,473
-24% -$7.4M 0.01% 1135
2021
Q1
$26.9M Sell
565,786
-42,493
-7% -$1.83M 0.01% 1103
2020
Q4
$18.3M Buy
608,279
+12,215
+2% +$312K 0.01% 1287
2020
Q3
$12.8M Buy
596,064
+112,198
+23% +$2.2M 0.01% 1379
2020
Q2
$10.5M Buy
483,866
+47,892
+11% +$884K ﹤0.01% 1510
2020
Q1
$5.81M Sell
435,974
-7,530
-2% -$254K ﹤0.01% 1802
2019
Q4
$21.3M Sell
443,504
-297
-0.1% -$12.3K 0.01% 1149
2019
Q3
$17.8M Sell
443,801
-218,049
-33% -$8.41M 0.01% 1233
2019
Q2
$28M Sell
661,850
-24,629
-4% -$1.09M 0.01% 947
2019
Q1
$31.3M Sell
686,479
-86,187
-11% -$3.95M 0.01% 889
2018
Q4
$34.2M Buy
772,666
+83,061
+12% +$3.59M 0.02% 773
2018
Q3
$32.5M Sell
689,605
-203,147
-23% -$8.87M 0.01% 982
2018
Q2
$35.5M Buy
892,752
+5,600
+0.6% +$239K 0.02% 830
2018
Q1
$36M Buy
887,152
+386,489
+77% +$14.3M 0.02% 812
2017
Q4
$16.3M Buy
500,663
+306,079
+157% +$8.41M 0.01% 1224
2017
Q3
$5.18M Sell
194,584
-92,570
-32% -$2.62M ﹤0.01% 2066
2017
Q2
$9.73M Sell
287,154
-240,834
-46% -$10.8M ﹤0.01% 1574
2017
Q1
$29.3M Buy
527,988
+61,626
+13% +$3.67M 0.02% 769
2016
Q4
$29M Buy
466,362
+284,546
+157% +$17.4M 0.02% 766
2016
Q3
$9.9M Buy
181,816
+14,275
+9% +$901K 0.01% 1463
2016
Q2
$10.8M Sell
167,541
-21,280
-11% -$1.41M 0.01% 1324
2016
Q1
$13.6M Sell
188,821
-22,496
-11% -$1.45M 0.01% 1184
2015
Q4
$12M Buy
211,317
+285
+0.1% +$16.5K 0.01% 1304
2015
Q3
$12M Buy
211,032
+12,462
+6% +$774K 0.01% 1306
2015
Q2
$13.1M Buy
198,570
+85,064
+75% +$5.84M 0.01% 1362
2015
Q1
$8.09M Buy
113,506
+5,361
+5% +$389K ﹤0.01% 1736
2014
Q4
$8.29M Sell
108,145
-10,443
-9% -$793K ﹤0.01% 1665
2014
Q3
$8.86M Sell
118,588
-13,453
-10% -$1.07M 0.01% 1572
2014
Q2
$10.8M Buy
132,041
+4,837
+4% +$370K 0.01% 1462
2014
Q1
$9.49M Buy
127,204
+1,289
+1% +$93.6K 0.01% 1565
2013
Q4
$9.2M Buy
125,915
+32,472
+35% +$2.27M 0.01% 1566
2013
Q3
$6.13M Sell
93,443
-37,072
-28% -$2.54M ﹤0.01% 1804
2013
Q2
$8.74M Buy
+130,515
New +$8.39M 0.01% 1517

Other funds holding GCO

Ameriprise's GCO Position: Q1 2026 in Review

Ameriprise opened a new position in Genesco (GCO) in Q1 2026: 55,446 shares worth $1.61M. The stake represents ﹤0.01% of the portfolio and ranks #3059 among its holdings. This is a return to the name: Ameriprise previously reported a position in GCO as recently as Q2 2025.

Ameriprise first reported a position in GCO in Q2 2013 and has held it in 50 quarters since. The position peaked at $36M in Q1 2018. 129 funds tracked by Wall St. Rank hold GCO as of Q1 2026.

  • Ameriprise held 55,446 shares of Genesco worth $1.61M as of Q1 2026.
  • Genesco was a new Ameriprise position in Q1 2026.
  • Genesco made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3059 holding.
  • Ameriprise first reported a position in Genesco in Q2 2013 and has held it in 50 quarters since.
  • Ameriprise's Genesco position peaked at $36M in Q1 2018.
  • 129 funds tracked by Wall St. Rank held Genesco as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.